JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

Search

Intuitive Surgical Inc

Închisă

SectorSănătate

474.04 0.83

Rezumat

Modificarea prețului

24h

Curent

Minim

469.77

Maxim

475.46

Indicatori cheie

By Trading Economics

Venit

-45M

658M

Vânzări

187M

2.4B

P/E

Medie Sector

67.603

34.393

EPS

1.81

Marjă de profit

26.984

Angajați

15,638

EBITDA

268M

987M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+28.25% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 oct. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-12B

173B

Deschiderea anterioară

473.21

Închiderea anterioară

474.04

Sentimentul știrilor

By Acuity

10%

90%

5 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bearish Evidence

Intuitive Surgical Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 iul. 2025, 21:13 UTC

Câștiguri

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 apr. 2025, 20:55 UTC

Câștiguri

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 ian. 2025, 21:41 UTC

Câștiguri

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 ian. 2025, 18:37 UTC

Achiziții, Fuziuni, Preluări

Intuitive to Establish Direct Presence in Europe With Acquisition

22 iul. 2025, 20:14 UTC

Câștiguri

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 iul. 2025, 20:13 UTC

Câștiguri

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 iul. 2025, 20:13 UTC

Câștiguri

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 iul. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 2Q Net $658.4M >ISRG

22 iul. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 iul. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 iul. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 iul. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 apr. 2025, 20:13 UTC

Câștiguri

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 apr. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 apr. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 apr. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 1Q Net $698.4M >ISRG

22 apr. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 apr. 2025, 20:05 UTC

Câștiguri

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 ian. 2025, 21:17 UTC

Câștiguri

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 ian. 2025, 18:18 UTC

Câștiguri

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 ian. 2025, 13:11 UTC

Top știri

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 ian. 2025, 09:51 UTC

Acțiuni populare

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 ian. 2025, 21:10 UTC

Câștiguri

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 ian. 2025, 21:09 UTC

Câștiguri

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 ian. 2025, 21:09 UTC

Câștiguri

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 ian. 2025, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 ian. 2025, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 ian. 2025, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 ian. 2025, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q Net $685.7M >ISRG

23 ian. 2025, 21:05 UTC

Câștiguri

Intuitive Surgical 4Q EPS $1.88 >ISRG

Comparație

Modificare preț

Intuitive Surgical Inc Așteptări

Obiectiv de preț

By TipRanks

28.25% sus

Prognoză pe 12 luni

Medie 602.89 USD  28.25%

Maxim 685 USD

Minim 440 USD

În baza a 22 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruIntuitive Surgical Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

22 ratings

17

Cumpărare

4

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

514.59 / 539.05Suport & Rezistență

Termen scurt

Weak Bearish Evidence

Termen mediu

Weak Bullish Evidence

Termen lung

Strong Bullish Evidence

Sentiment

By Acuity

5 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.